CurrentEndo
Get Weekly

Topic · page 7 of 12

Lipids & metabolic liver disease

Lipid disorders and metabolic dysfunction-associated steatotic (fatty) liver disease, as published in the endocrine journals

Briefs 241–280 of 460 placed here, newest publication first

Briefs in Lipids & metabolic liver disease

Newest publication first

  1. Diabetes Obes Metab

    Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials

    Secondary analysis

  2. Diabetes Obes Metab

    Inclisiran versus alirocumab in improving lipid profile parameters: A systematic review and meta‐analysis

    Meta-analysis

  3. Eur J Endocrinol

    Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study

    Cross-sectional study

  4. Diabetes Obes Metab

    Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study

    Cohort study

  5. Obesity (Silver Spring)

    The moderating effect of cardiometabolic factors on the association between hepatic and intrapancreatic fat

    Cross-sectional study

  6. J Clin Endocrinol Metab

    Homozygous Familial Hypercholesterolemia in Spain: Data From Registry of the Spanish Atherosclerosis Society

    Cohort study

  7. JAMA Intern Med

    GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

    Cohort study

  8. Cardiovasc Diabetol

    The triglyceride glucose: high-density lipoprotein cholesterol ratio is associated with coronary artery calcification evaluated via non-gated chest CT

    Cross-sectional study

  9. Lancet Diabetes Endocrinol

    Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study

    Research article

  10. Cardiovasc Diabetol

    Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial

    Secondary analysis

  11. Diabetes Metab

    Periodontitis adversely affects lipoprotein subfractions – results from the cohort study SHIP-TREND: Periodontitis adversely affects lipoprotein subfractions

    Cohort study

  12. Eur J Endocrinol

    Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans

    Cross-sectional study

  13. Pediatr Obes

    The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES

    Cross-sectional study

  14. BMJ Open Diabetes Res Care

    Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus

    Cross-sectional study

  15. Diabetes Obes Metab

    Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses

    Cohort study

  16. Eur Thyroid J

    Epigenetic regulation of thyroid hormone action in human metabolic dysfunction-associated steatohepatitis

    Mechanistic study

  17. Diabetes Res Clin Pract

    Computed tomography-based body composition indicative of diabetes after hypertriglyceridemic acute pancreatitis

    Cohort study

  18. J Clin Endocrinol Metab

    Associations Between Visceral and Liver Fat and Cardiac Structure and Function: A UK Biobank Study

    Cross-sectional study

  19. Diabetes Obes Metab

    Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study

    Diagnostic or prognostic study

  20. Int J Obes (Lond)

    Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency

    Research article

  21. Cardiovasc Diabetol

    Association of nonalcoholic fatty liver disease with new-onset atrial fibrillation stratified by age groups

    Cohort study

  22. J Clin Endocrinol Metab

    Incremental Value of Blood-Based Markers of Liver Fibrosis in Cardiovascular Risk Stratification

    Cohort study

  23. J Clin Endocrinol Metab

    Predictors of Cardiovascular Disease in Individuals With Dysbetalipoproteinemia: A Prospective Study in the UK Biobank

    Cohort study

  24. Endocr Pract

    Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis

    Meta-analysis

  25. J Clin Endocrinol Metab

    Comparison of Patients With Familial Chylomicronemia Syndrome and Multifactorial Chylomicronemia Syndrome

    Cohort study

  26. Diabetes Obes Metab

    Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis

    Research article

  27. Diabetes Obes Metab

    Birthweight influences liver structure, function and disease risk: Evidence of a causal association

    Research article

  28. Pediatr Obes

    Effect of Indo‐Mediterranean diet versus calorie‐restricted diet in children with non‐alcoholic fatty liver disease: A pilot randomized control trial

    Randomized controlled trial

  29. J Clin Endocrinol Metab

    Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology

    Cross-sectional study

  30. Cardiovasc Diabetol

    Prognostic effect of the TyG index on patients with severe aortic stenosis following transcatheter aortic valve replacement: a retrospective cohort study

    Cohort study

  31. Cardiovasc Diabetol

    Epicardial and liver fat implications in albuminuria: a retrospective study

    Cohort study

  32. Diabetes Obes Metab

    Independent and joint relationships of cardiorespiratory fitness and body mass index with liver fat content

    Cohort study

  33. Cardiovasc Diabetol

    Association between the atherogenic index of plasma trajectory and risk of heart failure among hypertensive patients: a prospective cohort study

    Cohort study

  34. Cardiovasc Diabetol

    Association of metabolic syndrome severity with frailty progression among Chinese middle and old-aged adults: a longitudinal study

    Cohort study

  35. J Clin Endocrinol Metab

    Statin Use and Development and Progression of Nonalcoholic Fatty Liver Disease Based on Ultrasonography

    Cohort study

  36. Int J Obes (Lond)

    Association of triglyceride-glucose index and its combination with adiposity-related indices with the incidence of myocardial infarction: a cohort study from the UK Biobank

    Cohort study

  37. Diabetes Res Clin Pract

    Glycated haemoglobin is a major predictor of disease severity in patients with NAFLD

    Diagnostic or prognostic study

  38. J Clin Endocrinol Metab

    Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents

    Cross-sectional study

  39. Diabetes Obes Metab

    Joint effects of sleep disturbance and renal function impairment on incident new‐onset severe metabolic dysfunction‐associated steatotic liver disease

    Cohort study

  40. Endocr Pract

    Objective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

    Cohort study

All 460 Briefs in ExploreShowing Briefs 241–280 of 460, newest first